Wed, Sep 20, 2023
Good growth in US generics market – which pharma stocks will benefit? Why did US business pick up pace? How is the growth in the US generic market - know in this video.
More >
Fri, Aug 25, 2023
Generic Medicine: What will happen to the plan to make treatment cheaper for the common man? NMC had issued new rules in the past, in which it was mandatory for all doctors to prescribe generic medicines. Failure to do so was said to cancel the license. But later the Indian Medical Association (IMA), Federation of Resident Doctors Association had approached the Central Government and Union Health Minister Mansukh Mandaviya in this regard, after which the decision has been put on hold. in the report.
Thu, Aug 24, 2023
Generic Drug Rules: The plan to reduce the cost of treatment has gone awry, why is there no reduction in your medical bills despite the availability of many options of cheap and good medicines in the market. Let's know the reason for this
Mon, Aug 14, 2023
Generic Medicines: National Medical Commission (NMC) has issued new rules. It has been said in the rules that all doctors should prescribe only generic medicines and if they do not do so then punitive action can be taken against them.
Wed, Jun 07, 2023
Generic Medicine: Why there is no reduction in your medical bill despite the availability of many options of cheap and good medicines in the market. Health department on behalf of Chief Minister Yogi Adityanath to provide better health facilities to the people of UP. are given directions
Fri, May 12, 2023
What is the government's new formula that can make generic medicines cheaper? Watch this video for more details.
Tue, Apr 07, 2020
India, the world`s main supplier of generic drugs, has lifted restrictions on the export of 24 pharmaceutical ingredients and medicines made from them, the government said in a statement
Sat, May 27, 2017
Sun Pharmaceutical Industries MD Dilip Shanghvi has said on Friday that the US sales might fall in 2018 because of pressure on drug prices, signalling tough market conditions in the United States (US) for generic drugmakers.
Mon, Dec 12, 2016
Glenmark and its partner Endo will be entitled to 180 days of generic drug exclusivity for ezetimibe.
Fri, Nov 11, 2016
The ongoing investigation by the US DoJ is likely to have limited impact on Indian pharma companies, said Fitch Ratings on Thursday.
Mon, Nov 07, 2016
The global generics sector saw a significant de-rating in YTD (year-to-date) in the CY2016 with 1-year forward P/E (price over equity) contracting by 34%, with the past one month itself witnessing an 11%.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
